Understanding Blood-Based Biomarkers in Alzheimer Disease

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

OUR INSANE HOUSE PARTY GONE WRONG! -You Should Know Podcast- 1h 21m · 21 Sep 2026 · You Should Know Podcast

Where is Austin Tice? 1. 'We believe he’s alive' 34 min · 21 Sep 2026 · The Documentary Podcast

Arsenal battered in Brighton as Manchester City go clear: Football Weekly 54 min · 21 Sep 2026 · Football Weekly

NPR News: 09-21-2026 8AM EDT 4 min · 21 Sep 2026 · NPR News Now

The Data Gold Rush_ Who Really Owns Your Digital Footprint 2 min · 21 Sep 2026 · Conspiracy Theories Exploring The Unseen

8AM ET 09/21/2026 Newscast 3 min · 21 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded05 May 2025

Publisherneurology.libsyn.com ↗

Handlerec:5447350

Show notes

Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at Neurology.org.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related